Colonial Trust Advisors’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History
Bought
Maintained
Sold
Other funds holding CALT
CGH
AP
MTIC
Colonial Trust Advisors's CALT Position: Q3 2024 in Review
Colonial Trust Advisors sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q3 2024, closing a stake of 105 shares — an estimated $4.09K sold.
Colonial Trust Advisors first reported a position in CALT in Q4 2022 and held it in 7 quarters. The position peaked at $4.09K in Q2 2024. 5 funds tracked by Wall St. Rank hold CALT as of Q3 2024.
- Colonial Trust Advisors reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q3 2024 after selling out during the quarter.
- Colonial Trust Advisors sold 105 Calliditas Therapeutics AB American Depositary Shares shares in Q3 2024, an estimated $4.09K.
- Colonial Trust Advisors first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q4 2022 and held it in 7 quarters.
- Colonial Trust Advisors's Calliditas Therapeutics AB American Depositary Shares position peaked at $4.09K in Q2 2024.
- 5 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q3 2024.
Based on Colonial Trust Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.